‘Doctors are highly motivated to know about clinical insights from the pharma industry’
DocPlexus, an online community for doctors, is building a bridge between pharma companies and doctors to improve clinical…
Author
Breaking the mould
Advanced Enzymes Technologies’ stellar debut at the stock exchange, despite the niche nature of its business, demonstrates that…
Experts condemn blanket ban on combination drugs at second edition of Vantage Point
Panelists highlight the need for proper guidelines and processes to weed out harmful FDCs from the market and ensure better safety…
Experts condemn blanket ban on combination drugs at second edition of Vantage Point
Panelists highlight the need for proper guidelines and processes to weed out harmful FDCs from the market and ensure better safety…
DRL launches nitroglycerin sublingual tablets in the US market
The Nitrostat (nitroglycerin) sublingual tablet brand had US sales of approximately $108 million MAT for the most recent twelve…
Shimadzu Corp launches new ICPMS 2030 in India
It is designed to help comply with USP 232/233 and ICH* Q3D guidelines for elemental impurities in pharma products
Shimadzu…
AstraZeneca updates on Phase III trial of Selumetinib in non-small cell lung cancer
Selumetinib did not meet trial endpoint of progression-free survival in KRASm NSCLC patients
AstraZeneca has announced results…
Morepen Labs announces financial results of Q1 2016-17
Company registered a 60 per cent increase in net profits for the first quarter
Morepen Laboratories has reported a 60 per cent…
GlaxoSmithKline Pharma declares Q1 financial performance
Net sales for the quarter came in at Rs 685 crores, recording a growth of eight per cent
GlaxoSmithKline Pharmaceuticals declared…
Almirall signs license agreement with Sun Pharma for Tildrakizumab in Europe for psoriasis
First IL-23p19 antibody to meet primary endpoints in pivotal phase-3 clinical trials in patients with moderate-to-severe plaque…